Search Results
Curcumenol 5 mg | 98.00%
TargetMol

Curcumenol, one of the major components of Zedoary turmeric oil, is an antibiotic drug which has anti-Y, anti-inflammation activity. Curcumenol may be safely used without inducing metabolic drug-drug interaction through P450 inhibition.
More Information Supplier Page4-Cyclohexylphenol 100 mg | 99.93%
TargetMol
4-Cyclohexylphenol is a biochemical compound for proteomics research.
More Information Supplier PageJervine 25 mg | 99.57%
TargetMol

The biological activity of Jervine is mediated via its interaction with the 7 passes transmembrane protein Smoothened. Jervine binds with and inhibits smoothened, which is an integral part of the Hedgehog signaling pathways. With smoothened inhibited, the GLI1 transcription cannot be activated and Hedgehog target genes cannot be transcribed.
More Information Supplier PageAntitumor agent-21 2 mg | Purity Not Available
TargetMol

Antitumor agent-21 (TRX818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
More Information Supplier PageSecoisolariciresinol diglucoside 5 mg | 100.00%
TargetMol

Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol Diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
More Information Supplier PageImportazole 200 mg | Purity Not Available
TargetMol

Importazole is an inhibitor of the nuclear transport receptor importin-β.
More Information Supplier PageMiransertib 1 mg | 98.00%
TargetMol

ARQ-092 is an orally bioavailable, selective, and potent allosteric Akt inhibitor.
More Information Supplier PageClofentezine 200 mg | 99.92%
TargetMol

Clofentezine is an active substance of plant protection product used as the pesticide, acaricide.
More Information Supplier PageTasimelteon 25 mg | Purity Not Available
TargetMol

Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.
More Information Supplier Page